FREE SHIPPING ON ORDERS $150+ • 10% OFF YOUR FIRST ORDER

Research Compound
NL-2 (TR)
NEXXUS internal designation for a dual incretin-receptor research peptide targeting GIP and GLP-1 receptor pathways. Studied in laboratory research involving gip receptor signaling. For laboratory research use only.
$164.98
$175.00
6% OFF
Strength
1
Laboratory research use only · Not for human or veterinary use
Select a strength to continue
Research Profile
Product Overview
NL-2 (TR) is NEXXUS internal designation for a dual incretin-receptor research peptide targeting GIP and GLP-1 receptor pathways. NEXXUS LABS supplies this material strictly for controlled laboratory research. Published work involving this material or its class may include in-vitro, ex-vivo, animal, analytical, or clinical-research settings depending on the compound. Research findings should not be interpreted as evidence of safety, efficacy, dosing, or suitability for consumer, human, or veterinary use.
Research Information
Research areas described in the scientific literature include: • Neuropeptide biology • sleep-related neurophysiology • peptide metabolism • central signaling research. These topics describe controlled research observations only. They are not medical claims, are not proof of safety or efficacy, and should not be used as guidance for administration or consumer use.
Analytical Characterization
Analytical Characterization
Each NEXXUS LABS research lot should be evaluated using the analytical documentation provided for that specific batch. The Certificate of Analysis (COA) is the controlling record for lot-specific identity and purity information.
Analytical documentation may include:
• HPLC or comparable chromatographic analysis for assessment of purity
• Mass spectrometric or other identity-confirmation data where provided
• Lot number and tested purity
• Physical-form and material-identification information
Purity data describes the tested material under the conditions of the reported analytical method. It does not establish sterility, clinical suitability, or fitness for human or veterinary use.
Researchers should refer to the COA associated with the exact lot received rather than relying solely on general product specifications.
Storage & Handling
Laboratory Storage & Handling
Store the material sealed, dry, protected from direct light, and under the conditions specified on the applicable product documentation or Certificate of Analysis.
Before opening material stored at reduced temperature, allow the sealed container to equilibrate appropriately to reduce the potential for moisture condensation.
Handle only using standard laboratory procedures and appropriate personal protective equipment. Avoid unnecessary exposure to moisture, heat, and repeated environmental changes. Researchers should follow their institution’s chemical-handling, storage, and waste-disposal procedures.
Where lot-specific storage instructions differ from general guidance, the lot-specific documentation should take priority.
For laboratory research use only. Not for human or veterinary use.
FAQ
What is NL-2 (TR)? NL-2 (TR) is NEXXUS internal designation for a dual incretin-receptor research peptide targeting GIP and GLP-1 receptor pathways. What is this product supplied for? It is supplied exclusively as a laboratory research material for qualified research settings. How should purity and identity be verified? Use the Certificate of Analysis tied to the exact lot received. The COA should be the primary source for lot-specific identity, purity, and analytical results. Can findings from published studies be assumed to apply outside those experiments? No. Results from laboratory, animal, or clinical research cannot be generalized beyond the conditions studied and do not establish safety or efficacy for other uses. Is this product intended for human or animal use? No. NEXXUS LABS designates this material for laboratory research use only. It is not intended for human consumption, veterinary use, diagnosis, treatment, or therapeutic administration.
Related Research Products



